---
title: "TARSUS PHARMACEUTICALS INC — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f3a8f101-e113-5e39-8d99-3758016686e6
json: https://whiteintel.dev/api/public/dossier/f3a8f101-e113-5e39-8d99-3758016686e6
identifier: cusip:87650L903
jurisdiction: US
source: WhiteIntel corporate-ownership graph
---

# TARSUS PHARMACEUTICALS INC

**Type:** Asset  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `cusip:87650L903`  
**Canonical dossier:** https://whiteintel.dev/entity/f3a8f101-e113-5e39-8d99-3758016686e6  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f3a8f101-e113-5e39-8d99-3758016686e6  

## Ownership & control

### UBO chain (walk to the ultimate owner)

A **2-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Provenance

- SEC 13F — https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **TARSUS PHARMACEUTICALS INC**. Human view: https://whiteintel.dev/entity/f3a8f101-e113-5e39-8d99-3758016686e6 · Structured JSON: https://whiteintel.dev/api/public/dossier/f3a8f101-e113-5e39-8d99-3758016686e6._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._